N4 Pharma (N4P) Competitors GBX 0.72 +0.10 (+16.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors N4P vs. RGT, MXC, HELD, HLN, HIK, HCM, INDV, AMYT, AGY, and APHShould you be buying N4 Pharma stock or one of its competitors? The main competitors of N4 Pharma include Argent BioPharma (RGT), Argent BioPharma (MXC), Hellenic Dynamics (HELD), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), and Alliance Pharma (APH). These companies are all part of the "drug manufacturers - specialty & generic" industry. N4 Pharma vs. Argent BioPharma Argent BioPharma Hellenic Dynamics Haleon Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Allergy Therapeutics Alliance Pharma Argent BioPharma (LON:RGT) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk. Do analysts recommend RGT or N4P? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Argent BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AN4 Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media prefer RGT or N4P? In the previous week, Argent BioPharma's average media sentiment score of 0.00 equaled N4 Pharma'saverage media sentiment score. Company Overall Sentiment Argent BioPharma Neutral N4 Pharma Neutral Does the MarketBeat Community believe in RGT or N4P? N4 Pharma received 103 more outperform votes than Argent BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformArgent BioPharmaN/AN/AN4 PharmaOutperform Votes10365.61% Underperform Votes5434.39% Do insiders and institutionals have more ownership in RGT or N4P? 1.1% of Argent BioPharma shares are held by institutional investors. 17.8% of Argent BioPharma shares are held by company insiders. Comparatively, 18.0% of N4 Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is RGT or N4P more profitable? Argent BioPharma's return on equity of 0.00% beat N4 Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Argent BioPharmaN/A N/A -108.57% N4 Pharma N/A -82.39%-56.00% Which has stronger earnings & valuation, RGT or N4P? N4 Pharma has higher revenue and earnings than Argent BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArgent BioPharmaN/AN/A-£17.53M-£0.24-71.46N4 Pharma£23.52K121.67-£1.08MN/AN/A Which has more risk & volatility, RGT or N4P? Argent BioPharma has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, N4 Pharma has a beta of -0.37, suggesting that its share price is 137% less volatile than the S&P 500. SummaryN4 Pharma beats Argent BioPharma on 6 of the 9 factors compared between the two stocks. Ad Porter & CompanyTicking time bomb. Detonation Nov 5Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Get N4 Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart N4P vs. The Competition Export to ExcelMetricN4 PharmaDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£2.86M£1.23B£5.04B£1.40BDividend Yield3.12%3.13%7.52%11.82%P/E Ratio-55.00100.61130.781,565.79Price / Sales121.672,780.491,683.11210,718.79Price / Cash2.2510.0236.9126.69Price / BookN/A3.184.602.86Net Income-£1.08M£138.28M£115.00M£153.77M7 Day Performance11.54%-0.06%-0.26%0.57%1 Month Performance20.83%-0.87%5.73%3.25%1 Year Performance-17.14%95.94%33.72%106.99% N4 Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)N4PN4 PharmaN/AGBX 0.73+16.0%N/A-24.8%£2.86M£23,524.00-55.005High Trading VolumeRGTArgent BioPharmaN/AGBX 18.85+7.7%N/AN/A£10.11MN/A-78.54N/AGap DownMXCArgent BioPharmaN/AGBX 22+4.8%N/AN/A£9.65M£1.32M-13.255Gap UpHELDHellenic DynamicsN/AGBX 0.95flatN/AN/A£1.40MN/A0.00N/ANews CoverageHLNHaleon0.9128 of 5 starsGBX 378.80+0.1%GBX 415+9.6%+16.2%£34.24B£11.26B3,156.6725,408HIKHikma Pharmaceuticals2.5452 of 5 starsGBX 1,915-0.9%GBX 2,325+21.4%+3.8%£4.25B£3.02B2,946.159,100HCMHUTCHMEDN/AGBX 303.20-4.4%N/A-10.3%£2.59B£610.81M-7,580.051,760INDVIndivior2.1044 of 5 starsGBX 705.50+2.0%GBX 1,500+112.6%-56.0%£907.20M£1.15B-881.881,000Gap UpAMYTAmryt PharmaN/AGBX 143-11.7%N/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 5.22+0.4%N/A+279.3%£248.99M£53.26M-87.00612Gap DownAPHAlliance Pharma2.6295 of 5 starsGBX 43.20+0.2%GBX 60+38.9%+18.7%£233.53M£183.15M-720.0091,000 Related Companies and Tools Related Companies Argent BioPharma Alternatives Argent BioPharma Alternatives Hellenic Dynamics Alternatives Haleon Alternatives Hikma Pharmaceuticals Alternatives HUTCHMED Alternatives Indivior Alternatives Amryt Pharma Alternatives Allergy Therapeutics Alternatives Alliance Pharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:N4P) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding N4 Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share N4 Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free N4P Stock Alerts